KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 129 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,072 | -25.1% | 800 | 0.0% | 0.00% | – |
| Q2 2023 | $1,432 | +47633.3% | 800 | -7.0% | 0.00% | – |
| Q1 2023 | $3 | 0.0% | 860 | +7.5% | 0.00% | – |
| Q4 2022 | $3 | -100.0% | 800 | -86.0% | 0.00% | – |
| Q3 2022 | $26,000 | +550.0% | 5,700 | +612.5% | 0.00% | – |
| Q2 2022 | $4,000 | -33.3% | 800 | 0.0% | 0.00% | – |
| Q1 2022 | $6,000 | -14.3% | 800 | 0.0% | 0.00% | – |
| Q4 2021 | $7,000 | +40.0% | 800 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | -37.5% | 800 | 0.0% | 0.00% | – |
| Q2 2021 | $8,000 | -81.4% | 800 | -80.2% | 0.00% | – |
| Q1 2021 | $43,000 | -31.7% | 4,050 | 0.0% | 0.00% | – |
| Q4 2020 | $63,000 | +23.5% | 4,050 | +15.7% | 0.00% | – |
| Q3 2020 | $51,000 | +218.8% | 3,500 | +311.8% | 0.00% | – |
| Q2 2020 | $16,000 | +45.5% | 850 | +44.1% | 0.00% | – |
| Q1 2020 | $11,000 | – | 590 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |